An adjuvanted zoster vaccine elicits potent cellular immune responses in mice without QS21

An adjuvanted zoster vaccine elicits potent cellular immune responses in mice without QS21

Herpes zoster (HZ) is caused by reactivation of latent varicella-zoster virus (VZV) when VZV-specific cellular immunity is insufficient to control reactivation. Currently, Shingrix, which contains the VZV gE protein and GSK’s AS01B adjuvant composed of liposomes formulated with cholesterol, monophos...

Full description

Bibliographic Details
Main Authors:	Carter, D. (Author), Casper, C. (Author), Hong, S.J (Author), Kim, J. (Author), Lee, A. (Author), Lee, S. (Author), Nam, H.J (Author), Reed, S.G (Author), Shin, E.-C (Author), Simeon, G. (Author)
Format:	Article
Language:	English
Published:	Nature Research 2022
Online Access:	View Fulltext in Publisher

Similar Items

Meta-Analysis on Randomized Controlled Trials of Vaccines with QS-21 or ISCOMATRIX Adjuvant: Safety and Tolerability.
by: Emilia Bigaeva, et al.
Published: (2016-01-01)

Abstract QS21: Leadership In Plastic Surgery
by: Carolyn P. Murphy, BA, et al.
Published: (2019-04-01)

Pristine large pore benzene-bridged mesoporous organosilica nanoparticles as an adjuvant and co-delivery platform for eliciting potent antitumor immunity
by: M. Jambhrunkar, et al.
Published: (2020-06-01)

Polymeric Pathogen-Like Particles-Based Combination Adjuvants Elicit Potent Mucosal T Cell Immunity to Influenza A Virus
by: Brock Kingstad-Bakke, et al.
Published: (2021-03-01)

Atomic Model and Micelle Dynamics of QS-21 Saponin
by: Conrado Pedebos, et al.
Published: (2014-03-01)

A Comparison of Intramuscular and Subcutaneous Administration of LigA Subunit Vaccine Adjuvanted with Neutral Liposomal Formulation Containing Monophosphoryl Lipid A and QS21
by: Teerasit Techawiwattanaboon, et al.
Published: (2020-09-01)

Mixed adjuvant formulations reveal a new combination that elicit antibody response comparable to Freund's adjuvants.
by: Rachel P J Lai, et al.
Published: (2012-01-01)

Bacterial-Derived Outer Membrane Vesicles Are Potent Adjuvants That Drive Humoral and Cellular Immune Responses
by: J. Timothy Prior, et al.
Published: (2021-01-01)

Evaluation of glycoprotein E subunit and live attenuated varicella‐zoster virus vaccines formulated with a single‐strand RNA‐based adjuvant
by: Su Jeen Lee, et al.
Published: (2020-06-01)

Clinical adjuvant combinations stimulate potent B-cell responses in vitro by activating dermal dendritic cells.
by: Katie Matthews, et al.
Published: (2013-01-01)

QsY-ST: Specification Transformation
by: Hsin-Ting Lee, et al.
Published: (2001)

Intracranial varicella zoster virus infection may elicit an unusual hyperkinetic volitional tremor
by: Ryogo Shobatake, et al.
Published: (2020-01-01)

IFNβ Is a Potent Adjuvant for Cancer Vaccination Strategies
by: Katherine M. Audsley, et al.
Published: (2021-09-01)

Abstract QS21: Exome Mutations In Sun-exposed Skin And Basal Cell Carcinoma
by: Sherry S. Collawn, MD, PhD, et al.
Published: (2020-04-01)

167 B-cell-based vaccination elicit potent immunity against glioblastoma
by: Peng Zhang, et al.
Published: (2020-11-01)

Abstract QS42: Neo - Adjuvant Chemotherapy is Not Associated With Increased Risk of Complications in Immediate Autologous Breast Reconstruction
by: Efstathios Karamanos, MD, et al.
Published: (2018-04-01)

A novel nonlive, adjuvanted herpes zoster subunit vaccine: a report on the emerging clinical data and safety profile
by: Brosio F, et al.
Published: (2018-09-01)

On the class of QS-algebras
by: Michiro Kondo
Published: (2004-01-01)

QS Ranking Methodologies
by: Newman, Janson
Published: (2018)

Adjuvant treatment of severe varicella pneumonia with intravenous varicella zoster virus-specific immunoglobulins
by: Davide Mangioni, et al.
Published: (2019-08-01)

Glucopyranosyl Lipid Adjuvant (GLA), a Synthetic TLR4 agonist, promotes potent systemic and mucosal responses to intranasal immunization with HIVgp140.
by: Mauricio A Arias, et al.
Published: (2012-01-01)

Nanoparticulate STING agonists are potent lymph node-targeted vaccine adjuvants
by: Crespo, Monica P., et al.
Published: (2015)

Glucopyranosyl lipid A adjuvant significantly enhances HIV specific T and B cell responses elicited by a DNA-MVA-protein vaccine regimen.
by: Paul F McKay, et al.
Published: (2014-01-01)

Kinesin-4 KIF21B is a potent microtubule pausing factor
by: Wilhelmina E van Riel, et al.
Published: (2017-03-01)

Potent neutralizing antibodies elicited by dengue vaccine in rhesus macaque target diverse epitopes.
by: Leike Li, et al.
Published: (2019-06-01)

A potent novel vaccine adjuvant based on straight polyacrylate
by: Marie Garinot, et al.
Published: (2020-12-01)

Nasionalisme Qurani dan Relevansinya dengan Semangat Kebangsaan Indonesia: Studi QS. [49]: 13, QS. [89]: 8 dan QS. [2]: 143
by: lufaefi Ptiq
Published: (2019-06-01)

Cost-Effectiveness of the Adjuvant Recombinant Zoster Vaccine in Japanese Adults Aged 65 Years and Older
by: Makoto Shiragami, et al.
Published: (2019-03-01)

Australian zoster study: GP and patient views about herpes zoster (shingles), its complications, and the likely acceptance of a zoster vaccine (Zostavax)
by: J.C.B. Litt, et al.
Published: (2014-04-01)

Acinetobacter baumannii outer membrane vesicles elicit a potent innate immune response via membrane proteins.
by: So Hyun Jun, et al.
Published: (2013-01-01)

BTK inhibitors impair humoral and cellular responses to recombinant zoster vaccine in CLL
by: Ahn, I.E, et al.
Published: (2022)

Herpes Zoster Ophthalmicus
by: J Gordon Millichap
Published: (1987-10-01)

Information Technology and the QS Practice
by: Peter Smith
Published: (2011-08-01)

Information Technology and the QS Practice
by: Peter Smith
Published: (2011-08-01)

Milk exosomes elicit a potent anti-viral activity against dengue virus
by: Afroz, S., et al.
Published: (2022)

Self-Assembled Nanofibers Elicit Potent HPV16 E7-Specific Cellular Immunity And Abolish Established TC-1 Graft Tumor
by: Li S, et al.
Published: (2019-10-01)

Family history of zoster and risk of developing herpes zoster
by: Hung Fu Tseng, et al.
Published: (2018-01-01)

Potent antibody lineage against malaria transmission elicited by human vaccination with Pfs25
by: Brandon McLeod, et al.
Published: (2019-09-01)

Effects of adjuvants on IgG subclasses elicited by virus-like Particles
by: Visciano Maria Luisa, et al.
Published: (2012-01-01)

Xanthine-based acyclic nucleoside phosphonates with potent antiviral activity against varicella-zoster virus and human cytomegalovirus
by: Ondřej Baszczyňski, et al.
Published: (2018-11-01)